Dr. Robert Guerrera, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 27 Danbury Rd, Wilton, CT 06897 Phone: 203-210-7820 Fax: 203-529-3385 |
Kussay Nassr, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 12 Crowne Pond Ln, Wilton, CT 06897 Phone: 267-978-8872 |
Dr. Francis J Hamilton Ii, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 432 Belden Hill Rd, Wilton, CT 06897 Phone: 203-834-0653 Fax: 203-834-0677 |
News Archive
John Niederhuber, a surgeon whom President Bush on Tuesday appointed as National Cancer Institute director, on Wednesday said that he hopes to find new nontoxic cancer medications but added that the agency likely will have to eliminate some programs because of budgetary issues, the New York Times reports.
Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for serious chronic infections, announced today it has entered into a research collaboration agreement with the PATH Malaria Vaccine Initiative (MVI) to conduct proof-of-concept studies with its proprietary, recombinant vesicular stomatitis virus (rVSV) vector technology as a preventative malaria vaccine.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
A literature review published in the August issue of the Journal of Periodontology (JOP) saw a strong relationship between stress and periodontal diseases; 57% of the studies included in the review showed a positive relationship between periodontal diseases and psychological factors such as stress, distress, anxiety, depression, and loneliness.
A new drug has been shown to improve the brain function of people with early stage Alzheimer's disease and reduce a key protein associated with the disease in the spinal fluid, in a small study published today in the journal Lancet Neurology and presented at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease.
› Verified 7 days ago